Citation: | MENG Tao, Zhang Yangmei, ZHANG Youwei, YUAN Yuan, LI Dechun. Exploring the mechanism of MCT 4 involved in the development of gastric cancer based on abnormal glucose metabolism[J]. Journal of Xuzhou Medical University, 2023, 43(8): 577-583. DOI: 10.3969/j.issn.2096-3882.2023.08.006 |
[1] |
Cao W,Chen HD,Yu YW,et al.Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J].Chin Med J (Engl),2021,134(7):783-791.
|
[2] |
Digklia A,Wagner AD.Advanced gastric cancer:current treatment landscape and future perspectives [J].World J Gastroenterol,2016,22(8):2403-2414.
|
[3] |
Zhang R,Li H,Li N,et al.Risk factors for gastric cancer:a large-scale,population-based case-control study[J].Chin Med J (Engl),2021,134(16):1952-1958.
|
[4] |
Felmlee MA,Jones RS,Rodriguez-Cruz V,et al.Monocarboxylatetransporters (SLC16):Function,regulation,and role in health and disease[J].Pharmacol Rev,2020,72(2):466-485.
|
[5] |
Payen VL,Mina E,Van Hée VF,et al.Monocarboxylate transporters in cancer[J].Mol Metab,2020,33:48-66.
|
[6] |
Deng W,Jiao N,Li N,et al.Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy[J].Biomed Pharmacother,2015,73:1-5.
|
[7] |
Vaupel P,Schmidberger H,Mayer A.The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression[J].Int J Radiat Biol,2019,95(7):912-919.
|
[8] |
Pouysségur J,Marchiq I,Parks SK,et al.'Warburg effect' controls tumor growth,bacterial,viral infections and immunity-Genetic deconstruction and therapeutic perspectives[J].Semin Cancer Biol,2022,86(Pt 2):334-346.
|
[9] |
万娟,程春芳,唐珊,等.乳酸作为信号分子作用的研究进展[J].中国细胞生物学学报2022,44(10):1980-1986.
|
[10] |
陈哲文,张杰,王正平,等.单羧酸转运载体与肿瘤代谢的关系[J].肿瘤代谢与营养电子杂志,2019,6(2):266-271.
|
[11] |
Contreras-Baeza Y,Sandoval PY,Alarcón R,et al.Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments[J].J Biol Chem,2019,294(52):20135-20147.
|
[12] |
孟涛,张杨梅,张有为,等.单羧酸转运蛋白4在结直肠癌中的表达及临床意义[J].中国医药导报,2020,17(15):8-11.
|
[13] |
徐帅帅,李硕,李浩,等.单羧酸转运蛋白4在胰腺癌中的表达及临床预后价值[J].中国临床医学,2020,27(5):730-734
|
[14] |
韩晟,周锦仁,邵青,等.MCT1在预测肝细胞癌患者预后中的作用研究 [J].南京医科大学学报(自然科学版),2022,42(2):184-188.
|
[15] |
Guo C,Huang T,Wang QH,et al.Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation,migration,and invasion of renal cancer cells[J/OL].Cancer Cell Int,2019,19:170.
|
[16] |
Yuan C,Zhang J,Lou J,et al.Comprehensive analysis of monocarboxylate transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis[J].Bioengineered,2021,12(1):3850-3863.
|
[17] |
Park SJ,Smith CP,Wilbur RR,et al.An overview of MCT1 and MCT4 in GBM: Small molecule transporters with large implications[J].Am J Cancer Res,2018,8(10):1967-1976.
|
[18] |
Wang Y,Qin L,Chen W,et al Novel strategies to improve tumour therapy by targeting the proteins MCT1,MCT4 and LAT1[J/OL].Eur J Med Chem,2021,226:113806.
|
[19] |
Saulle E,Spinello I,Quaranta MT,et al.Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation,induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells[J/OL].Front Oncol,2021,10:621458.
|
[20] |
Kuo TC,Huang KY,Yang SC,et al.Monocarboxylate transporter 4 is a therapeutic target in non-small cell lung cancer with aerobic glycolysis preference[J].Mol Ther Oncolytics,2020,18:189-201.
|
[21] |
王仲崑,张配,潘琼,等.单羧酸转运蛋白1抑制剂AZD3965对胃癌BCG-823细胞增殖和凋亡的影响 [J].蚌埠医学院学报,2018,43(12):1541-1545.
|
[22] |
Lee JY,Lee I,Chang WJ,et al.MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis [J].Oncotarget,2016,7(28):43492-43503.
|
[23] |
赵志,杨世斌,华立新,等.一元羧酸转运蛋白4在胃癌中的表达及与预后的关系[J].消化肿瘤杂志(电子版),2015,7(2):90-93.
|
[24] |
Pinheiro C,Longatto-Filho A,Simões K,et al.The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer[J].Eur J Cancer,2009,45(13):2418-2424.
|
[25] |
张在炬,陈亚明,丁正强.18F-FDG PET/CT代谢参数与胃癌临床病理特征的相关性分析[J].临床和实验医学杂志,2021,20(13):1450-1454.
|
[26] |
Sormendi S,Wielockx B.Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment[J/OL].Front Immunol,2018,9: 40.
|
[27] |
Semenza GL.Hypoxia-inducible factor 1:Oxygen homeostasis and disease pathophysiology[J].Trends Mol Med,2001,7(8):345-350.
|
[28] |
Cheng SC,Quintin J,Cramer RA,et al.mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity[J].Science,2014,345(6204):1250684.
|
[29] |
Kierans SJ,Taylor CT.Regulation of glycolysis by the hypoxia-inducible factor (HIF): Implications for cellular physiology[J].J Physiol,2021,599(1):23-37.
|
[30] |
Ullah MS,Davies AJ,Halestrap AP.The plasma membrane lactate transporter MCT4,but not MCT1,is up-regulated by hypoxia through a HIF-1 alpha-dependent mechanism[J].J Biol Chem,2006,281(14):9030-9037.
|
[31] |
娜仁.HIF-1α/MCT4对乳腺癌细胞糖酵解及增殖的影响[D].呼和浩特:内蒙古医科大学,2021.
|